Associations Between miRNAs and Two Different Cancers: Breast and Colon


Kundaktepe B. P., SÖZER V., PAPİLA Ç., DURMUŞ S., Kocael P. C., ŞİMŞEK G., ...Daha Fazla

CANCER MANAGEMENT AND RESEARCH, cilt.12, ss.871-879, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12
  • Basım Tarihi: 2020
  • Doi Numarası: 10.2147/cmar.s227628
  • Dergi Adı: CANCER MANAGEMENT AND RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.871-879
  • İstanbul Üniversitesi Adresli: Evet

Özet

Objective: Screening approaches using microRNAs (miRNAs) have been gaining increased attention owing to their potential applications in the diagnosis, prognosis, and monitoring of cancer, because aberrant miRNA expression plays a role in the development and advancement of malignancies. The objectives of this study were to characterize mir21, miR31, mir143, mir145, and control RNU43, which are differentially expressed in peripheral blood mononuclear cells (PBMCs) of breast and colorectal cancer patients, compared to that in controls and to establish whether this is specific to breast and colon cancer for use as tumor markers.